Latest H5N1 clinical trials Stories
The FDA this week approved Fluzone High-Dose, an inactivated influenza virus vaccine for people ages 65 years and older to prevent disease caused by influenza virus subtypes A and B.
One dose of vaccine may be effective to protect infants and children and reduce transmission of the H1N1 virus, according to a study in JAMA, published online today because of its public health implications.
LYON, France and SWIFTWATER, Pa., Dec. 15 /PRNewswire-FirstCall/ -- Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that it is expanding its phase II clinical study of a vaccine against Clostridium difficile infection (CDI) into the United States.
The European Medicines Agency announced that young children who are receiving GlaxoSmithKline's H1N1 vaccine may contract a fever after the second injection.
ROCKVILLE, Md., Dec. 2 /PRNewswire-FirstCall/ -- Novavax, Inc.
BEIJING, Dec. 1 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.
ROCKVILLE, Md., Nov. 30 /PRNewswire-FirstCall/ -- Novavax, Inc.
The WHO said on Tuesday that GlaxoSmithKline recalled a batch of swine flu vaccine in Canada after a number of severe allergic reactions surfaced.
The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) on Monday voiced concerns about the sluggish vaccination rate for the H1N1 swine flu due to public skepticism over health risks and side effects.
ROCKVILLE, Md., Nov. 16 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announced today that enrollment has been completed in the first stage of a two-stage clinical study of its novel 2009 H1N1 virus-like-particle (VLP) pandemic influenza unadjuvanted vaccine in the country of Mexico.
- One of a pair of round metal cymbals attached to the fingers and struck together for rhythm and percussion in belly dancing.